Circulating oxidized low density lipoprotein levels: A biochemical risk marker for coronary heart disease

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 10, 2000, Pages 2243-2247

  Toshima, Shun Ichi ^a,b   Hasegawa, Akira ^a   Kurabayashi, Masahiko ^a   Itabe, Hiroyuki ^d   Takano, Tatsuya ^d   Sugano, Jinpei ^c   Shimamura, Kyoko ^e   Kimura, Junji ^e   Michishita, Ichiro ^f   Suzuki, Toru ^g   Nagai, Ryozo ^g,h  

^a GUNMA UNIVERSITY   (Japan)

^b SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^c Department of Radiology   (Japan)

^d TEIKYO UNIVERSITY   (Japan)

^e Vessel Research Laboratory Inc   (Japan)

^f Yokohama Sakae Kyosai Hospital   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

Author keywords

Coronary heart disease; Oxidized low density lipoprotein; Risk factors

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; LOW DENSITY LIPOPROTEIN;

ADULT; AGE; AGED; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GENDER; HUMAN; ISCHEMIC HEART DISEASE; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN MODIFICATION; RISK FACTOR;

EID: 0033789815     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.10.2243     Document Type: Article

References (31)

1. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
2. Role of oxidized low density lipoprotein in atherogenesis
3. Oxidized lipoproteins, altered cell function and atherosclerosis
4. Conner Memorial Lecture: Oxidative modification of LDL and atherogenesis
5. Atherosclerosis: Basic mechanisms: Oxidation, inflammation, and genetics
6. Beyond cholesterol: Modifications of low-density lipoprotein that increase its atherogenicity
7. The pathogenesis of atherosclerosis: A perspective for the 1990s
8. Role of oxidised low density lipoprotein in atherogenesis
9. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
10. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes
11. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
12. Transferable lipids in oxidized low-density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells
13. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins: Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation
14. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
15. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins
16. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-β mRNA in stimulated murine peritoneal macrophages
17. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid
18. 7β-Hydroperoxycholest-5-en-3β-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein
19. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: Smoking as a cause of oxidative damage
20. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease
21. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease
22. Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure
23. Cloning of monoclonal auto-antibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice: Demonstration of epitopes of oxidized low density lipoprotein in human plasma
24. A monoclonal antibody against oxidized lipoprotein recognizes foam ceils in atherosclerotic lesions
25. Oxidized phosphatidylcholines that modify proteins
26. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody
27. Identification and quantitation of choline glycerophospholipids that contain aldehyde residues by fluorometric high-performance liquid chromatography
28. Autoantibody tilers to oxidized low-density lipoprotein in patients with coronary atherosclerosis
29. Antibody against oxidized low-density lipoprotein predicting myocardial infarction
30. Oxidative cross-linking of apoprotein B100 and hemoglobin results in low density lipoprotein modification in blood: Relevance to atherogenesis caused by hemodialysis
31. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects